Atomistry » Bromine » PDB 5o62-5q0c » 5o7i
Atomistry »
  Bromine »
    PDB 5o62-5q0c »
      5o7i »

Bromine in PDB 5o7i: ERK5 in Complex with A Pyrrole Inhibitor

Enzymatic activity of ERK5 in Complex with A Pyrrole Inhibitor

All present enzymatic activity of ERK5 in Complex with A Pyrrole Inhibitor:
2.7.11.24;

Protein crystallography data

The structure of ERK5 in Complex with A Pyrrole Inhibitor, PDB code: 5o7i was solved by J.A.Tucker, A.Heptinstall, S.Myers, with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:

Resolution Low / High (Å) 48.65 / 2.38
Space group P 41 21 2
Cell size a, b, c (Å), α, β, γ (°) 93.910, 93.910, 113.748, 90.00, 90.00, 90.00
R / Rfree (%) 18.1 / 22

Other elements in 5o7i:

The structure of ERK5 in Complex with A Pyrrole Inhibitor also contains other interesting chemical elements:

Fluorine (F) 1 atom

Bromine Binding Sites:

The binding sites of Bromine atom in the ERK5 in Complex with A Pyrrole Inhibitor (pdb code 5o7i). This binding sites where shown within 5.0 Angstroms radius around Bromine atom.
In total only one binding site of Bromine was determined in the ERK5 in Complex with A Pyrrole Inhibitor, PDB code: 5o7i:

Bromine binding site 1 out of 1 in 5o7i

Go back to Bromine Binding Sites List in 5o7i
Bromine binding site 1 out of 1 in the ERK5 in Complex with A Pyrrole Inhibitor


Mono view


Stereo pair view

A full contact list of Bromine with other atoms in the Br binding site number 1 of ERK5 in Complex with A Pyrrole Inhibitor within 5.0Å range:
probe atom residue distance (Å) B Occ
A:Br501

b:67.2
occ:0.33
BR A:9N8501 0.0 67.2 0.3
C A:9N8501 1.9 64.0 1.0
C1 A:9N8501 2.8 62.8 1.0
H A:9N8501 2.9 62.8 1.0
C5 A:9N8501 2.9 63.0 1.0
C6 A:9N8501 3.2 60.4 1.0
O1 A:9N8501 3.2 62.4 1.0
CD1 A:LEU189 3.6 48.9 1.0
CA A:GLY199 3.6 39.3 1.0
N A:ASP200 3.6 43.7 1.0
CG A:LEU189 3.7 47.5 1.0
CD2 A:LEU189 3.7 48.4 1.0
C A:GLY199 3.8 45.0 1.0
C2 A:9N8501 4.1 62.6 1.0
C4 A:9N8501 4.2 62.2 1.0
C7 A:9N8501 4.2 57.4 1.0
O A:HOH608 4.2 51.7 1.0
CB A:ASP200 4.3 47.6 1.0
O A:ASN187 4.4 40.7 1.0
N A:GLY199 4.4 39.8 1.0
CA A:ASP200 4.5 44.0 1.0
H10 A:9N8501 4.6 55.5 1.0
O A:GLY199 4.6 44.6 1.0
C3 A:9N8501 4.7 61.6 1.0
CA A:ASN187 4.7 41.9 1.0
OD1 A:ASN187 4.7 66.8 1.0
C16 A:9N8501 4.8 55.4 1.0
C A:ASN187 4.8 40.9 1.0
H1 A:9N8501 4.9 63.1 1.0

Reference:

S.M.Myers, D.C.Miller, L.Molyneux, M.Arasta, R.H.Bawn, T.J.Blackburn, S.J.Cook, N.Edwards, J.A.Endicott, B.T.Golding, R.J.Griffin, T.Hammonds, I.R.Hardcastle, S.J.Harnor, A.B.Heptinstall, P.A.Lochhead, M.P.Martin, N.C.Martin, D.R.Newell, P.J.Owen, L.C.Pang, T.Reuillon, L.J.M.Rigoreau, H.D.Thomas, J.A.Tucker, L.Z.Wang, A.C.Wong, M.E.M.Noble, S.R.Wedge, C.Cano. Identification of A Novel Orally Bioavailable ERK5 Inhibitor with Selectivity Over P38 Alpha and BRD4. Eur.J.Med.Chem. V. 178 530 2019.
ISSN: ISSN 0223-5234
PubMed: 31212132
DOI: 10.1016/J.EJMECH.2019.05.057
Page generated: Mon Jul 7 08:52:56 2025

Last articles

Na in 7AKT
Na in 7AHK
Na in 7A6A
Na in 7A6B
Na in 7AGN
Na in 7AGB
Na in 7AGD
Na in 7AFY
Na in 7AEZ
Na in 7AES
© Copyright 2008-2020 by atomistry.com
Home   |    Site Map   |    Copyright   |    Contact us   |    Privacy